Skip to main content
. 2015 May 8;6(26):22996–23007. doi: 10.18632/oncotarget.4035

Table 2. Comparison of the survival distributions of patients sub-grouped based on miRNA expression.

Survival analysis: PFS for patients with low vs high miRNA expressing tumors
miRNA p-value Log-rank test adjusted p-value Log-rank test
1 miR-16 0.095 0.249
2 miR-18a 0.524 0.576
3 miR-19b 0.468 0.544
4 miR-21 0.329 0.483
5 miR-26b 0.995 0.995
6 miR-31 0.276 0.433
7 miR-34a 0.196 0.376
8 miR-92a 0.040 0.219
9 miR-93 0.023 0.168
10 miR-103 0.160 0.351
11 miR-125b 0.055 0.219
12 miR-137 0.060 0.219
13 miR-140 0.856 0.897
14 miR-143 0.001 0.012
15 miR-145 0.100 0.249
16 miR-148a 0.390 0.536
17 miR-191 0.205 0.376
18 miR-192 0.102 0.249
19 miR-215 0.009 0.095
20 miR-222 0.470 0.544
21 miR-let7a 0.464 0.544
22 miR-let7g 0.244 0.413